MGI Tech Launches New MGISP-Smart 8 Automated Sample Preparation System at MEDLAB Middle East
By LabMedica International staff writers Posted on 24 Jan 2022 |

MGI Tech Co. Ltd. (Shenzhen, China) unveiled its new MGISP-Smart 8 automated sample preparation system at MEDLAB Middle East 2022 held at the Dubai World Trade Center.
The event marked the debut of the MGISP-Smart 8 in international markets outside of China, where it was launched in October 2021. MGISP-Smart 8 will now be available in markets outside of China in April 2022. Additionally, MGI Tech also showcased its DNBSEQ-G400 and DNBSEQ-G50 gene sequencing platforms, MGISTP-3000 automated sample transfer processing system, mobile platform for automated and integrated nucleic acid testing.
MGISP-Smart 8 is an independent 8-channel pipetting robot that achieves flexible and customizable lab automation with several innovations in the pipette and gripper functions, such as independent multi-channel dynamic positioning and dual-level liquid detection. Equipped with high-end core technologies, such as an independent 8-channel pipette, intelligent integrated gripper and triple slide track design, MGISP-Smart 8 meets a variety of different application needs, from sequencing library preparation to nucleic acid detection and sample preparation.
MGISP-Smart 8 automates the pipetting and gripper function, which are two core functions for laboratories. With its independent eight-channel pipette for cherry-picking, the system flexibly and efficiently controls pipetting for a variety of lab scenarios and tasks. The system's pipetting volume ranges from 1μL to 1000μL, and eight independent pipettes support dual-level liquid detection for capacitance and pressure. MGISP-Smart 8 is also capable of undertaking pipette functions for different volumes, different channels and unequal intervals - making it adaptable to microplates, reservoirs and tubes. Meanwhile, the high precision integrated rotatable gripper directly connects to the peripheral integration instrument and detects gripping status in real-time to ensure experiment stability.
Beyond the pipette and gripper functions, MGISP-Smart 8 is extremely user-friendly and flexible with exceptional attention to details. The main workstation's triple stacked sliding deck design is adaptable to different modules, allowing users to flexibly combine modules like building blocks and conveniently replace modules at any time for applications' protocols. With 36 independent sliding tracks on the deck, MGISP-Smart 8 supports up to 30 SBS-standard layouts and works with seven types of consumable carriers. All tracks and deck positions are equipped with a position-sensing function, as well as induction functions to avoid misplacement errors in carrier and consumable advancement. MGISP-Smart 8 also works with different types of functional modules and is compatible with third-party kits with flexible software. As a flexible automated pipetting system, MGISP-Smart 8 covers different application scenarios in genomics, cell biology, proteomics, drug development, microbial screening and more. By fully automating operations, laboratories can improve efficiency; reduce errors in complex, repetitive liquid handling protocols; and free out researchers from tedious sample preparation work so they can devote more time onto more valuable tasks.
"Since our inception, MGI has been committed to developing our automated sample preparation systems business. The MGISP-960 and MGISP-100 have helped simplify tedious sample preparation tasks and been well-received by the international medical and scientific community, while the MGISTP-7000 automated sample transfer processing system and MGISP-NE384 automated nucleic acid extractor have supported pandemic prevention efforts for a number of countries worldwide. With the new MGISP-Smart 8, we have once again made a major breakthrough in lab automation. MGISP-Smart 8 builds on our existing systems with greater flexibility, intelligence and customization – enabling us to provide comprehensive lab automatic workflow for more fields and applications," said Dr. Roy Tan, General Manager of MGI Asia Pacific.
Related Links:
MGI Tech Co. Ltd.
Latest Medlab 2022 News
- EUROIMMUN Presents EUROPattern Microscope Live with EUROLabOffice 4.0 Software for Ultrafast Automated Microscopy
- PerkinElmer Exhibits Automated Nucleic Acid Extraction Solutions at MEDLAB Middle East
- Abbott Displays Its Life-Changing POC Tests and Diagnostic Tools at MEDLAB Middle East
- Diagast Presents Latest Immunohaematology Solutions at MEDLAB Middle East
- Siemens Brings Its Latest Innovations in Laboratory Diagnostics to MEDLAB Middle East 2022
- Bioperfectus Showcases Its Molecular Diagnostic Products for Infectious Diseases at MEDLAB 2022 Online
- Seegene Showcases New STARlet-AIOS All-in-One Solution for All Molecular Testing at MEDLAB Middle East
- LumiraDx Presents Its Next-Generation POC Diagnostics Platform and Fast Lab Solutions at MEDLAB Middle East
- Randox Highlights Its Innovative Diagnostic Products Revolutionizing Healthcare at MEDLAB Middle East
- Beckman Coulter Demonstrates Newly Launched DxA 5000 Fit Workflow Automation System at MEDLAB Middle East
- Horiba Presents Comprehensive Range of Hematology, Hemostasis and Clinical Chemistry Analyzers at MEDLAB Middle East
- GC Labs Highlight Its “Smart Lab” Concept at MEDLAB Middle East 2022
- MEDLAB Middle East and Arab Health 2022 Edition Return as Co-Located Events for Healthcare and Laboratory Industries
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more